IE39283B1 - Tablet formulation - Google Patents
Tablet formulationInfo
- Publication number
- IE39283B1 IE39283B1 IE1097/74A IE109774A IE39283B1 IE 39283 B1 IE39283 B1 IE 39283B1 IE 1097/74 A IE1097/74 A IE 1097/74A IE 109774 A IE109774 A IE 109774A IE 39283 B1 IE39283 B1 IE 39283B1
- Authority
- IE
- Ireland
- Prior art keywords
- allopurinol
- agent
- starch
- tablet formulations
- disintegrating agent
- Prior art date
Links
- 239000007916 tablet composition Substances 0.000 title abstract 3
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000003979 granulating agent Substances 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 201000001431 Hyperuricemia Diseases 0.000 abstract 1
- 229920000881 Modified starch Polymers 0.000 abstract 1
- 229920000715 Mucilage Polymers 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 229920001938 Vegetable gum Polymers 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 229960003459 allopurinol Drugs 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000019426 modified starch Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 abstract 1
- 229920003109 sodium starch glycolate Polymers 0.000 abstract 1
- 229940079832 sodium starch glycolate Drugs 0.000 abstract 1
- 239000008109 sodium starch glycolate Substances 0.000 abstract 1
- 229940032147 starch Drugs 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2462873A GB1460302A (en) | 1973-05-23 | 1973-05-23 | Tablet formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE39283L IE39283L (en) | 1974-11-23 |
| IE39283B1 true IE39283B1 (en) | 1978-09-13 |
Family
ID=10214700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1097/74A IE39283B1 (en) | 1973-05-23 | 1974-05-22 | Tablet formulation |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS577128B2 (enExample) |
| AT (1) | AT351167B (enExample) |
| AU (1) | AU469472B2 (enExample) |
| BE (1) | BE815409A (enExample) |
| CA (1) | CA977279A (enExample) |
| CY (1) | CY941A (enExample) |
| DE (1) | DE2424950A1 (enExample) |
| DK (1) | DK144261C (enExample) |
| FI (1) | FI156674A7 (enExample) |
| FR (1) | FR2230341B1 (enExample) |
| GB (1) | GB1460302A (enExample) |
| HK (1) | HK1378A (enExample) |
| HU (1) | HU170656B (enExample) |
| IE (1) | IE39283B1 (enExample) |
| IL (1) | IL44877A (enExample) |
| IT (1) | IT8048966A0 (enExample) |
| KE (1) | KE2808A (enExample) |
| MY (1) | MY7800181A (enExample) |
| NL (1) | NL190436C (enExample) |
| SE (1) | SE402525C (enExample) |
| ZA (1) | ZA743318B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1533243A (en) * | 1975-02-13 | 1978-11-22 | Wellcome Found | Tablet formulation |
| US4143129A (en) | 1975-10-11 | 1979-03-06 | Lilly Industries Limited | Cephalexin tablets |
| US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| DE3839825A1 (de) * | 1988-11-25 | 1990-06-13 | Henning Berlin Gmbh | Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze |
| WO1996002234A1 (es) * | 1994-07-18 | 1996-02-01 | Luis Cipriano Carvajal Martin | Granulos compactos altamente autodisgregantes para uso en formas galenicas conteniendo principios activos insolubles o poco solubles |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB975850A (en) * | 1955-08-10 | 1964-11-18 | Wellcome Found | Xanthine oxidase inhibitors |
| US3624205A (en) * | 1967-04-25 | 1971-11-30 | Burroughs Wellcome Co | Treatment of hyperuricemia in humans |
-
1973
- 1973-05-23 GB GB2462873A patent/GB1460302A/en not_active Expired
-
1974
- 1974-05-22 AT AT426774A patent/AT351167B/de not_active IP Right Cessation
- 1974-05-22 ZA ZA00743318A patent/ZA743318B/xx unknown
- 1974-05-22 IE IE1097/74A patent/IE39283B1/xx unknown
- 1974-05-22 JP JP5776774A patent/JPS577128B2/ja not_active Expired
- 1974-05-22 FR FR7417820A patent/FR2230341B1/fr not_active Expired
- 1974-05-22 DK DK280174AA patent/DK144261C/da not_active IP Right Cessation
- 1974-05-22 IL IL44877A patent/IL44877A/en unknown
- 1974-05-22 NL NLAANVRAGE7406873,A patent/NL190436C/xx not_active IP Right Cessation
- 1974-05-22 DE DE19742424950 patent/DE2424950A1/de active Pending
- 1974-05-22 CA CA200,536A patent/CA977279A/en not_active Expired
- 1974-05-22 BE BE144636A patent/BE815409A/xx not_active IP Right Cessation
- 1974-05-22 FI FI1566/74A patent/FI156674A7/fi unknown
- 1974-05-22 HU HUWE507A patent/HU170656B/hu unknown
- 1974-05-22 SE SE7406864A patent/SE402525C/sv not_active IP Right Cessation
- 1974-05-22 AU AU69252/74A patent/AU469472B2/en not_active Expired
- 1974-05-23 CY CY941A patent/CY941A/xx unknown
- 1974-12-02 KE KE2808A patent/KE2808A/xx unknown
-
1978
- 1978-01-05 HK HK13/78A patent/HK1378A/xx unknown
- 1978-12-31 MY MY1978181A patent/MY7800181A/xx unknown
-
1980
- 1980-06-13 IT IT8048966A patent/IT8048966A0/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE815409A (fr) | 1974-11-22 |
| FR2230341B1 (enExample) | 1977-04-15 |
| CA977279A (en) | 1975-11-04 |
| DK144261B (enExample) | 1982-02-01 |
| DK144261C (da) | 1991-02-04 |
| MY7800181A (en) | 1978-12-31 |
| IE39283L (en) | 1974-11-23 |
| FR2230341A1 (enExample) | 1974-12-20 |
| NL190436B (nl) | 1993-10-01 |
| SE402525B (sv) | 1978-07-10 |
| NL7406873A (enExample) | 1974-11-26 |
| AT351167B (de) | 1979-07-10 |
| SE402525C (sv) | 1982-11-22 |
| KE2808A (en) | 1978-02-17 |
| IL44877A (en) | 1976-11-30 |
| JPS577128B2 (enExample) | 1982-02-09 |
| GB1460302A (en) | 1977-01-06 |
| AU469472B2 (en) | 1976-02-12 |
| NL190436C (nl) | 1994-03-01 |
| AU6925274A (en) | 1975-11-27 |
| IT8048966A0 (it) | 1980-06-13 |
| HK1378A (en) | 1978-01-13 |
| HU170656B (enExample) | 1977-07-28 |
| IL44877A0 (en) | 1974-07-31 |
| DE2424950A1 (de) | 1974-12-19 |
| ZA743318B (en) | 1975-05-28 |
| FI156674A7 (enExample) | 1974-11-24 |
| ATA426774A (de) | 1978-12-15 |
| CY941A (en) | 1978-06-23 |
| JPS5040721A (enExample) | 1975-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES430431A1 (es) | Varistor de oxido metalico. | |
| IL56557A (en) | 6-substituted 2-penem-3-carboxylic acid derivatives,their production and pharmaceutical compositions containing them | |
| GB1405088A (en) | Slow release formulation | |
| CY1219A (en) | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof and process for their manufacture | |
| AU576197B2 (en) | Particulate n-acetyl-p-aminophenol composition | |
| DE3461054D1 (en) | Divisible tablet with sustained release of the active ingredient, and process for its production | |
| EP0213761A3 (en) | Stable sodium aspirin tablet compositions | |
| AU7084587A (en) | Methylprednisolone/sodium carboxymethyl starch tablet composition | |
| GB1227534A (enExample) | ||
| EP0237241A3 (en) | Calcium supplement compressed tablets | |
| IE39283L (en) | Tablet formulation | |
| AU4392179A (en) | Antacid tablet formulation | |
| IL57229A0 (en) | Hydroxypropyl-imidazole derivatives,their production and pharmaceutical compositions containing them | |
| IL59391A (en) | 7-pyrazolyl-oximinoacetylamino-cephalosporanic acid derivatives,their production and chemotherapeutical compositions containing them | |
| GB1464200A (en) | Pharmaceutical composition | |
| DE3260227D1 (en) | Composition that contains acesulfame, tablets on the basis of this composition and process for their production | |
| ZA794580B (en) | N-phenylindoline derivatives,their production and pharmaceutical compositions containing them | |
| CA930745A (en) | 9-azolylfluorene-9-carboxylic acid derivatives, a process for their production, and their use for the regulation of plant growth | |
| GB1268146A (en) | Improvements in or relating to a contraceptive cervical obturator | |
| GB1291559A (en) | N-(4-chlorocinnamoyl)-4-hydroxypiperidine | |
| GB1533243A (en) | Tablet formulation | |
| IL56696A0 (en) | Nitroso-urea derivatives,their production and pharmaceutical compositions containing them | |
| GB1263839A (en) | A novel aminoethanesulfonic acid | |
| AU2009970A (en) | Novel pharmaceutically active 4_acylamino-1,2,4-triazol derivatives and a process for their preperation | |
| GB1287433A (en) | Pharmaceutical compositions |